-
AXA IM rehires Magda Branet for EM role
10 February 2022To head emerging markets and Asian fixed income
-
Vaccine equity: a case study in investor engagement
07 February 2022Investors have asked pharma companies in a letter to address COVID vaccine equity. Two signatories, Achmea and Storebrand, reveal the content of their engagement toolbox to hold investee companies to account.
-
"You can't have everything": can CIOs strike a balance between ESG and returns?
26 January 2022Panellists at IAR's Asia conference discuss sacrificing balance sheets, for better ESG credentials, as Abbie Wood reports
-
AXA IM Alts appoint Rob Samuel as head of UK development
24 January 2022The UK continues to be one of the asset manager's "most important markets"
-
AXA IM expects a 'solid' 2022
20 January 2022Predicting the normalisation of inflation and credit spreads remaining stable
-
Hong Kong regulation's benefits more than numerical, insurers say
19 January 2022Capital charge numbers are an important part of Hong Kong's RBC, but insurers tell David Walker that the qualitative improvements they expect in how underwriters manage their risk will be as important
-
IAR Asia 2022: Day 2 round up
12 January 2022Conference's last day on 13 January will tackle sustainable finance
-
IAR Asia: Insurers welcome risk-based capital - across the region
12 January 2022Hong Kong and China regulators each recently tweaked rules
-
AXA IM Alts increases US industrial portfolio
17 December 2021It is acquiring a $2bn portfolio of 32 assets
-
Axa France purchases €3m unsecured bonds in the form of 'security tokens'
09 December 2021Blockchain transaction carried out by affiliated asset manager